Hasil Pencarian - Angelo Cortesi

  • Menampilkan 1 - 20 hasil dari 20
Perbaiki Hasil
  1. 1
    The Value and Sustainability of Ocrelizumab in Relapsing Multiple Sclerosis: A Cost-Effectiveness and Budget Impact Analysis

    The Value and Sustainability of Ocrelizumab in Relapsing Multiple Sclerosis: A Cost-Effectiveness and Budget Impact Analysis oleh Paolo Angelo Cortesi, Damiano Paolicelli, Marco Capobianco, Paolo Cozzolino, Lorenzo Giovanni Mantovani

    Diterbitkan 2019-07-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Cost-Effectiveness of Dimethyl Fumarate Compared to Teriflunomide for Relapsing Remitting Multiple Sclerosis Patients in Italy

    Cost-Effectiveness of Dimethyl Fumarate Compared to Teriflunomide for Relapsing Remitting Multiple Sclerosis Patients in Italy oleh Lorenzo Giovanni Mantovani, Paolo Angelo Cortesi, Alessandra Cardillo, Laura Santoni, Luca Prosperini

    Diterbitkan 2022-02-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    The Economic Burden of Different Multiple Sclerosis Courses: Analysis from Italian Administrative and Clinical Databases

    The Economic Burden of Different Multiple Sclerosis Courses: Analysis from Italian Administrative and Clinical Databases oleh Paolo Angelo Cortesi, Paolo Cozzolino, Ruggero Capra, Giancarlo Cesana, Lorenzo Giovanni Mantovani

    Diterbitkan 2020-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    Simulation of an Oxic-Settling-Anaerobic Pilot Plant Operated under Real Conditions Using the Activated Sludge Model No.2d

    Simulation of an Oxic-Settling-Anaerobic Pilot Plant Operated under Real Conditions Using the Activated Sludge Model No.2d oleh Rosa Vitanza, Angelo Cortesi, Vittorino Gallo, Maria E. De Arana, Ioanna A. Vasiliadou

    Diterbitkan 2021-12-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    [Use of Kovaltry® in patients with Hemophilia A: clinical and economical aspects from the pivotal clinical trials]

    [Use of Kovaltry® in patients with Hemophilia A: clinical and economical aspects from the pivotal clinical trials] oleh Lucia Sara D'Angiolella, Angelo Claudio Molinari, Paolo Angelo Cortesi, Antonio Coppola, Lorenzo Giovanni Mantovani

    Diterbitkan 2017-02-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  6. 6
    Cost-effectiveness and budget impact analysis of siponimod in the treatment of secondary progressive multiple sclerosis in Italy

    Cost-effectiveness and budget impact analysis of siponimod in the treatment of secondary progressive multiple sclerosis in Italy oleh Paolo Angelo Cortesi, Ippazio Cosimo Antonazzo, Claudio Gasperini, Mihaela Nica, Daniela Ritrovato, Lorenzo Giovanni Mantovani

    Diterbitkan 2022-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  7. 7
    Cost-effectiveness and budget impact analysis of siponimod in the treatment of secondary progressive multiple sclerosis in Italy.

    Cost-effectiveness and budget impact analysis of siponimod in the treatment of secondary progressive multiple sclerosis in Italy. oleh Paolo Angelo Cortesi, Ippazio Cosimo Antonazzo, Claudio Gasperini, Mihaela Nica, Daniela Ritrovato, Lorenzo Giovanni Mantovani

    Diterbitkan 2022-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  8. 8
    [Cost-effectiveness analysis of delayed-release dimethyl-fumarate in the treatment of relapsing-remitting multiple sclerosis in Italy]

    [Cost-effectiveness analysis of delayed-release dimethyl-fumarate in the treatment of relapsing-remitting multiple sclerosis in Italy] oleh Gianluca Furneri, Laura Santoni, Chiara Marchesi, Sergio Iannazzo, Paolo Angelo Cortesi, Achille Patrizio Caputi, Lorenzo Giovanni Mantovani

    Diterbitkan 2016-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  9. 9
    Critical Review of the Pivotal Studies of Four rFVIII Products for the Treatment of Hemophilia A Patients: The Role of Octocog Alfa

    Critical Review of the Pivotal Studies of Four rFVIII Products for the Treatment of Hemophilia A Patients: The Role of Octocog Alfa oleh Matteo Nicola Dario Di Minno, Lucia D'Angiolella, Paolo Angelo Cortesi, Angelo Claudio Molinari, Lorenzo Giovanni Mantovani

    Diterbitkan 2020-04-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  10. 10
    [Nintedanib for the treatment of idiopathic pulmonary fibrosis in Italy]

    [Nintedanib for the treatment of idiopathic pulmonary fibrosis in Italy] oleh Andrea Belisari, Daria Bettoni, Paolo Angelo Cortesi, Lucia Sara D'Angiolella, Lorenzo Giovanni Mantovani, Gerardo Miceli Sopo, Marino Nonis

    Diterbitkan 2017-04-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  11. 11
    Agarose Cryogels: Production Process Modeling and Structural Characterization

    Agarose Cryogels: Production Process Modeling and Structural Characterization oleh Raffaele Mancino, Diego Caccavo, Anna Angela Barba, Gaetano Lamberti, Alice Biasin, Angelo Cortesi, Gabriele Grassi, Mario Grassi, Michela Abrami

    Diterbitkan 2023-09-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  12. 12
    Neuroprotective Properties of Cardoon Leaves Extracts against Neurodevelopmental Deficits in an In Vitro Model of Rett Syndrome Depend on the Extraction Method and Harvest Time

    Neuroprotective Properties of Cardoon Leaves Extracts against Neurodevelopmental Deficits in an In Vitro Model of Rett Syndrome Depend on the Extraction Method and Harvest Time oleh Mariachiara Spennato, Ottavia Maria Roggero, Simona Varriale, Fioretta Asaro, Angelo Cortesi, Jan Kašpar, Enrico Tongiorgi, Cinzia Pezzella, Lucia Gardossi

    Diterbitkan 2022-12-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  13. 13
    Health Technology Assessment on the use of the Wearable Cardioverter Defibrillator in Patients with Myocardial Infarction and with ICD Explant

    Health Technology Assessment on the use of the Wearable Cardioverter Defibrillator in Patients with Myocardial Infarction and with ICD Explant oleh Paolo Angelo Cortesi, Giovanni Luca Botto, Lucia D'Angiolella, Luciana Scalone, Roberto De Ponti, Giuseppe Boriani, Lorenzo Giovanni Mantovani

    Diterbitkan 2021-04-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  14. 14
    Cost-Utility Analysis of Bariatric Surgery in Italy: Results of Decision-Analytic Modelling

    Cost-Utility Analysis of Bariatric Surgery in Italy: Results of Decision-Analytic Modelling oleh Marcello Lucchese, Oleg Borisenko, Lorenzo Giovanni Mantovani, Paolo Angelo Cortesi, Giancarlo Cesana, Daniel Adam, Elisabeth Burdukova, Vasily Lukyanov, Nicola Di Lorenzo

    Diterbitkan 2017-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  15. 15
    [Tecfidera® (delayed-release dimethylfumarate) in the treatment of relapsing-remitting multiple sclerosis]

    [Tecfidera® (delayed-release dimethylfumarate) in the treatment of relapsing-remitting multiple sclerosis] oleh Lorenzo Giovanni Mantovani, Gianluca Furneri, Paolo Angelo Cortesi, Maria Pia Amato, Achille Patrizio Caputi, Patrizio Piacentini, Alessandra Solari, Carlo Pozzilli, Giancarlo Comi

    Diterbitkan 2017-12-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  16. 16
    Cost-effectiveness analysis of oral fentanyl formulations for breakthrough cancer pain treatment.

    Cost-effectiveness analysis of oral fentanyl formulations for breakthrough cancer pain treatment. oleh Paolo Angelo Cortesi, Lucia Sara D'Angiolella, Renato Vellucci, Massimo Allegri, Giuseppe Casale, Carlo Favaretti, Flavia Kheiraoui, Giancarlo Cesana, Lorenzo Giovanni Mantovani

    Diterbitkan 2017-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  17. 17
    A cost-consequence analysis of adding pertuzumab to the neoadjuvant combination therapy in HER2-positive high-risk early breast cancer in Italy

    A cost-consequence analysis of adding pertuzumab to the neoadjuvant combination therapy in HER2-positive high-risk early breast cancer in Italy oleh Alberto Zambelli, Marina Cazzaniga, Nicla La Verde, Elisabetta Munzone, Ippazio Cosimo Antonazzo, Lorenzo Giovanni Mantovani, Serena Di Cosimo, Anna Mancuso, Daniele Generali, Paolo Angelo Cortesi

    Diterbitkan 2023-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  18. 18
    Personalized Prophylaxis with myPKFiT<sup>CE</sup>: A Real-World Cost-Effectiveness Analysis in Haemophilia A Patients

    Personalized Prophylaxis with myPKFiT<sup>CE</sup>: A Real-World Cost-Effectiveness Analysis in Haemophilia A Patients oleh Ippazio Cosimo Antonazzo, Paolo Angelo Cortesi, Ezio Zanon, Samantha Pasca, Massimo Morfini, Cristina Santoro, Raimondo De Cristofaro, Giovanni Di Minno, Paolo Cozzolino, Lorenzo Giovanni Mantovani

    Diterbitkan 2023-12-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  19. 19
    The global patient-reported outcomes for multiple sclerosis initiative: bridging the gap between clinical research and care – updates at the 2023 plenary event

    The global patient-reported outcomes for multiple sclerosis initiative: bridging the gap between clinical research and care – updates at the 2023 plenary event oleh Paola Zaratin, Sara Samadzadeh, Sara Samadzadeh, Sara Samadzadeh, Meral Seferoğlu, Vito Ricigliano, Vito Ricigliano, Jonadab dos Santos Silva, Jonadab dos Santos Silva, Abdulkadir Tunc, Giampaolo Brichetto, Timothy Coetzee, Anne Helme, Usman Khan, Robert McBurney, Guy Peryer, Helga Weiland, Peer Baneke, Mario Alberto Battaglia, Valerie Block, Luca Capezzuto, Loïc Carment, Paolo Angelo Cortesi, Gary Cutter, Letizia Leocani, Letizia Leocani, Hans-Peter Hartung, Hans-Peter Hartung, Hans-Peter Hartung, Hans-Peter Hartung, Jan Hillert, Jeremy Hobart, Kaisa Immonen, Paul Kamudoni, Rod Middleton, Patricia Moghames, Xavier Montalban, Liesbet Peeters, Maria Pia Sormani, Susanna van Tonder, Susanna van Tonder, Angela White, Giancarlo Comi, Patrick Vermersch

    Diterbitkan 2024-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  20. 20
    Italy's health performance, 1990–2017: findings from the Global Burden of Disease Study 2017

    Italy's health performance, 1990–2017: findings from the Global Burden of Disease Study 2017 oleh Lorenzo Monasta, Cristiana Abbafati, Giancarlo Logroscino, Giuseppe Remuzzi, Norberto Perico, Boris Bikbov, Giorgio Tamburlini, Ettore Beghi, Eugenio Traini, Sofia Boston Redford, Filippo Ariani, Antonio M Borzì, Cristina Bosetti, Giulia Carreras, Valeria Caso, Giulio Castelpietra, Massimo Cirillo, Sara Conti, Paolo Angelo Cortesi, Giovanni Damiani, Lucia Sara D'Angiolella, Jessica Fanzo, Carla Fornari, Silvano Gallus, Giorgia Giussani, Giuseppe Gorini, Giuseppe Grosso, Davide Guido, Carlo La Vecchia, Paolo Lauriola, Matilde Leonardi, Miriam Levi, Fabiana Madotto, Stefania Mondello, Luigi Naldi, Stefano Olgiati, Raffaele Palladino, Cristiano Piccinelli, Marco Piccininni, Elisabetta Pupillo, Alberto Raggi, Salvatore Rubino, Paola Santalucia, Marco Vacante, Simone Vidale, Francesco S Violante, Mohsen Naghavi, Luca Ronfani

    Diterbitkan 2019-12-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: